Exclusive agreement covers 13 Central and Eastern European marketsCollaboration will help expand access to VANFLYTA for ...

Program will expand access in certain regions where Revuforj is not available commercially, as permitted by local regulations -- Program will ...

Curis, Inc. , a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 and FLT3 inhibitor, today announced that it has entered into a ...

FaceTec, the global leader in 3D Face Verification software, is thrilled to announce the appointment of Cameron D'Ambrosi as Head of Strategic Partnerships for North America and the European Union as ...

This article was originally published on www.si.com/college/stanford as Stanford Lands Former Michigan Quarterback in ...

Leading CEOs mull shareholder concerns and wildcard predictions for the 2026 gambling sector including maintaining ...

As Indian SMEs accelerate plans to expand into the UAE, banking and compliance have emerged as the real gatekeepers of market ...

The deal brings Dark Blue's preclinical oncology products, including an MLLT1/3-targeted agent for leukemias, into Amgen's portfolio.

How Modern Technology Shapes the iGaming Experience The iGaming industry has evolved rapidly over ...

The gut bacteria B. adolescentis eased lung scarring in a pulmonary fibrosis mouse model, showing potential as a preventive ...

Changes in motor units closely reflect disease severity in people with spinal muscular atrophy (SMA), suggesting potential ...